Peer-reviewed

Sensitive Skin Pathophysiology in Infants

  • Jan 30, 2026
  • 40 Reviews
Sensitive Skin Pathophysiology in Infants

Sensitive skin in infants is a common clinical concern characterized by impaired cutaneous barrier function and heightened reactivity to environmental stimuli. Clinical evidence suggests an estimated global prevalence of sensitive skin in the pediatric population is approximately 53.9%1. In India, the prevalence is comparatively lower yet remains substantial, with an estimated rate of 32.3%2.

Increasing evidence in pediatric dermatology highlights the importance of early-life skin barrier integrity, as barrier dysfunction in infancy has been linked to an increased risk of developing atopic disorders later in life.

Pathophysiology of the Infant Skin Barrier

Infant skin differs substantially from adult skin in both structure and function, largely due to its relative immaturity and reduced thickness.

  • Structural differences between adult and infant skin: The epidermis, particularly the stratum corneum, is thinner and less fully developed in infants, resulting in diminished barrier efficiency. This structural immaturity increases susceptibility to environmental irritants, microbial penetration, and inflammatory responses. Infant skin also exhibits higher transepidermal water loss (TEWL) and reduced moisture retention, predisposing it to dryness, irritation, and fluid imbalance3.
  • Functional differences: Infant skin has a higher surface pH (approximately 5.5–6.5) compared to adult skin4, which interferes with lipid-processing enzymes and antimicrobial defense. Delayed formation of the acid mantle compromises barrier maturation and microbial protection. Despite higher water content, limited water-binding capacity leads to hydration instability.
  • Molecular and immunological factors:
    • Genetic factors: Mutations in the filaggrin (FLG) gene impair cornified envelope formation and reduce natural moisturizing factors, leading to compromised barrier integrity5. Variations in lipid synthesis genes further disrupt lamellar organization.
    • Inflammatory mediators: Barrier disruption triggers proinflammatory cytokines such as IL-1, IL-33, and thymic stromal lymphopoietin, promoting inflammation and allergic sensitization. A Th2-skewed immune response in infants amplifies this process.

Vulnerability of the Impaired Skin Barrier in Infants and Preterm Newborns

The underdeveloped skin barrier in infants, especially preterm neonates, increases susceptibility to microbial invasion, irritant damage, and inflammation. Preterm infants are particularly vulnerable due to immature stratum corneum and lipid structures, making early-life skin protection and targeted interventions essential6.

Clinical Manifestations of Sensitive Skin in Infants

Clinically, sensitive infant skin presents with erythema, xerosis, irritant reactions, and increased susceptibility to contact dermatitis, with severity ranging from mild transient sensitivity to chronic inflammatory conditions.

Conclusion

Sensitive skin in infants arises from an underdeveloped barrier and heightened reactivity, increasing susceptibility to irritants, microbes, and inflammation. Early identification and targeted skin care are essential to support barrier maturation, maintain hydration, and reduce the risk of long-term dermatological and atopic complications in both term and preterm infants.

Emollients play a pivotal role in managing sensitive infant skin by enhancing barrier function, restoring lipid composition, improving hydration, and reducing TEWL, thereby mitigating irritation and supporting healthy skin development.

References

  1. Misery L, Taïeb C, Brenaut E, et al. Sensitive Skin in Children. Acta Derm Venereol. 2020;100(1):adv00039.
  2. Brenaut E, Misery L, Taieb C. Sensitive Skin in the Indian Population. Front Med (Lausanne). 2019;6:29.
  3. Kong F, Galzote C, Duan Y. Change in skin properties over the first 10 years of life. Arch Dermatol Res. 2017;309(8):653–658.
  4. Telofski LS, et al. The infant skin barrier. Dermatol Res Pract. 2012;2012:198789.
  5. Gupta J, Margolis DJ. Filaggrin gene mutations. Curr Treat Options Allergy. 2020;7(3):403–413.
  6. Oranges T, Dini V, Romanelli M. Skin Physiology of the Neonate. Adv Wound Care. 2015;4(10):587–595.
Peer Review

Doctor Reviews 0

Verified clinical perspectives shared by healthcare professionals across the country.